Cytalux (pafolacianine) is an imaging agent used during surgery to help detect ovarian cancer and lung cancer tumors in adults. It’s given as an infusion through the vein before surgery. The agent works by attaching to cancer cells and makes them “light up”, so surgeons can see them with special imaging equipment. This helps find cancer that might be missed by the naked eye. Common side effects include nausea and vomiting.
To help surgeons detect areas with:
Cytalux (pafolacianine) is an optical imaging agent. It works by attaching folate receptors, which are proteins found at higher amounts on cancer cells. After the agent enters the cell, it absorbs light and gives off a fluorescence glow. This “light up” effect makes cancer cells easier to find and remove during surgery.
Source: DailyMed
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
Helps detect hidden or hard-to-see cancer cells
Approved for both ovarian and lung cancer tumors
Given as a single dose before surgery
Commonly causes infusion-related reactions
Only given in centers with specific imaging equipment
You’ll get Cytalux (pafolacianine) as an infusion through a vein over 60 minutes. It’s typically given 1 to 24 hours before surgery, depending on the cancer that’s being detected.
Avoid taking folic acid or folate supplements within 48 hours before your Cytalux (pafolacianine) infusion. This medication targets folate receptors, and extra folate could make it work less well.
Cytalux (pafolacianine) can cause infusion-related reactions. Your care team might give you antihistamines or antinausea medications to lower this risk. Be sure to report side effects like nausea, vomiting, chest discomfort, or stomach pain.
You might have to take a pregnancy test to confirm that you aren’t pregnant before receiving Cytalux (pafolacianine). This is because the medication might cause harm to an unborn baby.
Cytalux (pafolacianine) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Some people have infusion-related reactions while receiving Cytalux (pafolacianine). These can include nausea, vomiting, stomach pain, flushing, allergic reactions, indigestion, and chest discomfort. Usually, these reactions happened within the first 15 minutes of starting the infusion.
To help prevent serious reactions, your care team might give you antihistamines or antinausea medications before the infusion. If you do have a reaction, your care team might slow down or stop the infusion and treat your symptoms. If your reaction is mild, they might restart the infusion once you feel better.
Cytalux (pafolacianine) helps your surgeon see cancer during surgery. But there’s always a chance that it might mark healthy tissue as cancerous (false positive) or miss cancer that’s there (false negative). If you’re worried about this risk, talk with your surgeon.
Cytalux (pafolacianine) might harm an unborn baby. Your care team will give you a pregnancy test before treatment to make sure it’s safe for you to receive this medication.
The dose of Cytalux (pafolacianine) is based on your body weight. Your care team will calculate your exact dose and decide when to give it, depending on your cancer:
Ovarian cancer: The typical dose is 0.025 mg/kg given as an infusion through the vein, between 1 hour to 9 hours before surgery.
Lung cancer: The typical dose is 0.025 mg/kg given as an infusion through the vein, between 1 hour to 24 hours before surgery.
By providing your email, you consent to receive marketing communications from GoodRx, which may include content and/or data related to men’s health, women's health, reproductive care, or sexual health. You agree to the GoodRx Terms of Use and acknowledge the Privacy Policy. You can unsubscribe at any time.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.